Biodistribution and pharmacokinetics of recombinant, human 125I-interleukin-2 in mice-Reference-Cited by-同舟云学术

Biodistribution and pharmacokinetics of recombinant, human 125I-interleukin-2 in mice

Published:1989-01 Issue:4 Volume:11 Page:411-416
ISSN:0192-0561
Container-title:International Journal of Immunopharmacology
language:en
Short-container-title:International Journal of Immunopharmacology

Author:

Sands Howard,Loveless Scott E.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology

Reference19 articles.

1. Systemic administration of recombinant human interleukin-2 in mice;Chang;J. biol. Resp. Mod.,1984

2. Plasma concentration profiles of human recombinant interleukin-2 (HrIL-2) in the rat following administration by various systemic routes;Colburn;Drug Met. Disp.,1987

3. The fate of interleukin-2 following in vivo administration;Donohue;J. Immun.,1983

4. The preparation of 131I-labeled normal growth hormone of high specific radioactivity;Greenwood;Biochem. J.,1963

5. Recombinant interleukin-2 stimulate in vivo proliferation of adaptively transferred lymphokine activated killer (LAK) cells;Ettinghausen;J. Immun.,1985

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression;Cancer Immunology Research;2022-03-14

2. Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy;European Journal of Nuclear Medicine and Molecular Imaging;2021-06-02

3. GMCSF-Interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer;Journal of Internal Medicine;2010-12-16

4. ReGel® Polymer-based Delivery of Interleukin-2 as a Cancer Treatment;Journal of Immunotherapy;2006-09

5. Effect of albumin fusion on the biodistribution of interleukin-2;Cancer Immunology, Immunotherapy;2004-05-01